Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-29 21:25:17 - browse：41

The FDA building -- First Opinion coverage from STAT — Adobe

U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an option to patients who have been advocating for access to the medicine.

The treatment, an oral medication that will be marketed as Sohonos, faced some questions about the quality of its data, and was rejected earlier this year by European regulators. But in approving the drug for the treatment of fibrodysplasia ossificans progressiva, or FOP, the Food and Drug Administration concluded that Sohonos’ benefits outweigh its risks.

“I just closed my eyes and looked up to the skies, like ‘Thank you, God,’” said Suzanne Hollywood, whose teenage son, Joey, has been receiving the drug in a clinical trial. “It’s far from perfect, but I’m thrilled for my son, for his future, and for the kids getting diagnosed who might not have to experience what others had to.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Why palliative psychiatry is worth discussing

WSS

More doctors should go into startup world

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

A solution to the after

More doctors should go into startup world

Why palliative psychiatry is worth discussing

Ambulance rides for just $100? Advisers want major billing fixes

leisure time

Wikipedia

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

New documents shed light on MD Anderson Cancer Institute feud

In age of alternative facts, a scholarly course on calling out crap

Why palliative psychiatry is worth discussing

Wildfire smoke exposes gaps in outdoor worker protections

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Apple is now the first public company to be valued at $3 trillion

Alabama IVF ruling threatens families facing fatal genetic disease

Psychedelics group wrestles with new pharma identity

Community Health Systems hospitals under DOJ investigation

focus

UCSF medical school apologizes for unethical prisoner experiments

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

PBM reform efforts get punted in Congress

With competition flaring, obesity drug hits goal in liver disease study

Community Health Systems hospitals under DOJ investigation

leisure time

knowledge

hotspot

knowledge